
|Articles|April 16, 2007
FDA weighs improving medication guides
The agency is especially interested in getting views from consumers, pharmacies, manufacturers, wholesalers, and researchers.
Advertisement
The FDA is holding a hearing on medication guides. The goal is to find ways to improve the development, distribution, comprehensibility, and accessibility of these documents, which provide drug risk information to patients. The hearing will be held on June 12 to 13 at the National Transportation and Safety Board Boardroom and Conference Center in Washington, D.C. The agency is especially interested in getting views from consumers, pharmacies, manufacturers, wholesalers, and researchers. For more information, refer to the notice in the April 9 Federal Register or go to
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5







































